The media components necessary for deriving and sustaining organoids from a number of epithelial tissues such as prostate, colon, gastric, liver, pancreas, and others have been established (1). Critical components of organoid media formulations are a set of growth factors that include EGF, R-spondins and BMP signalling antagonists such as Noggin or Gremlin. The practical limitation to organoid culture and the development of new applications for the technology is the use of defined cellular activities of growth factors in media formulations, in particular Noggin/Gremlin 1 and R-spondin 1. Here we report the production of highly pure recombinant Gremlin 1 and R-spondin 1 from bacterial expression and their use for culturing organoids. We detail the workflow for their purification, determination of cellular activity, quality control and their formulation in organoid media. The protocols we provide for generation of precisely formulated, cost-effective, organoid media of defined cellular activity will enable broader access to organoid technology and engender the development of novel applications.
Introduction
The development of organoid technology has proven to be scientifically transformative with tremendous potential for application to the fields of epithelial biology and pathology and for clinical applications such as the generation of patient-derived organoid biobanks (2, 3) . The critical component of organoid technology is the formulation of culture media with essential growth factors, in particular -R-spondin family members that potentiate Wnt pathway activity and BMP pathway inhibitors such as Gremlin 1 or Noggin 1 that inhibit differentiation cues. Currently, the production of growth factors for organoid media relies on eukaryotic expression systems to ensure correct disulphide bond formation and macromolecular folding. Typically, in eukaryotic expression systems, growth factors are secreted into the cell culture media from the expression hosts, and this conditioned media, containing the growth factor of choice (and all other proteins those cells naturally secrete), is then diluted directly into organoid culture media. However, R-spondin 1 and Gremlin 1/Noggin 1 expressing cell lines are not widely available and the use of conditioned media presents the problems of batch-to-batch variation of growth factor activity. Moreover, the presence of proteins, including growth factors, from serum present in cell culture media as well as those secreted from those cells may impact organoid growth. Commercially available purified growth factors can also be used to supplement organoid media however, these are expensive for medium to large scale applications such as genetic and chemical library screening or clinical biobanking of organoids. Moreover, commercial growth factors preparations can retain impurities from conditioned media that prevent accurate and reproducible determination of their cellular activities.
Here, we report a protocol for the generation of highly pure recombinant Gremlin 1 and R-spondin 1 from bacterial expression that contain negligible levels of endotoxin and free from impurities endemic to production using eukaryotic expression systems. We detail protocols for the determination of the cellular activities of the growth factors enabling the generation of media of reproducible potencies for organoids culture circumventing the issue of batch-to-batch variation. The production of defined and reproducible organoid media potencies has broad application for the culturing of organoids derived from a number of tissue types.
Materials and Methods

Expression plasmids
The pR-spondin 1 construct for production of R-spondin 1 is based on a previously reported pETDuetbased vector (4) for dual expression of a R-spondin 1-containing fusion protein (maltose binding protein, a tetra-cysteine tag, a thrombin cleavage site, residues 21-145 of human R-spondin 1 (Uniprot: O60565) and a hexa-histidine tag) and the E. coli disulphide bond isomerase, DsbC. We have inserted the coding sequence of Avi-tag upstream of the R-spondin 1 transgene by digestion of the original construct with BamHI and NotI and Gibson assembly to create pR-spondin 1 (Fig. 2A) .
Plasmids for testing R-spondin 1 activity in the potentiation of Wnt pathway activity are the Super 8x TOPFlash (SuperTop; Addgene 12456) and the Renilla Luciferase control reporter vector pRL-SV40P (Promega).
The expression construct, pHAT4-N-Grem1, encoding for a protein with hexa-histidine tag, TEV protease cleavage site and amino acids 72-184 of human Gremlin 1 (Uniprot: O60565), has been described previously ((5); Fig. 3A) . Expression of human BMP2 from the bacterial plasmid pBAT-BMP2 and its purification has been detailed elsewhere (5) .
Cell lines
HEK293T and C2C12 cells were obtained from ATCC. The cell lines are routinely screened for mycoplasma contamination and validated by short tandem repeat DNA profiling (STR) and DNA fingerprinting as described in the ATCC SDO Workgroup ASN-0002 Standards document (6) .
Organoid media components
Components of the respective media formulations for each organoid type used in the study, listed in Table 1 , are as follows: Base media -Advanced DMEM F12 (Gibco) containing 1X penicillin/streptomycin and 10 mM HEPES buffer pH 7.0. Supplements include the following: B27 and N2 supplements (Gibco), N-acetyl-L-cysteine (NAC; Sigma-Aldrich), human gastrin 1 (SigmaAldrich), A83-01 (Sigma-Aldrich), SB202190 (Sigma-Aldrich), prostaglandin E2 (PGE2; SigmaAldrich), Gastrin I (Sigma-Aldrich), nicotinamide (Sigma-Aldrich) and Primocin (InvivoGen).
Commercially-sourced growth factors used in the study are: R-spondin 1 (amino acids 31-263; cat.
4645-RS-025), Gremlin 1 (cat. 5190-GR-050), FGF-2 (cat. 233-FB-010), Neuregulin-1/NRG-1 (cat.
396-HB/CF) and EGF (cat. 236-EG-200), all from R&D Systems. All organoids were grown in growth factor reduced, serum free Matrigel (Fisher Scientific).
Expression and purification of R-spondin 1
Expression of the R-spondin 1 fusion protein from pR-spondin 1 was carried out in the host E. coli Eluted fractions containing MBP-R-spondin 1 were pooled and concentrated using an Amicon Ultra-15 centrifuge filter (Millipore). Buffer exchange into disulphide reshuffling buffer (50 mM Tris base, pH 8.0 containing 150 mM NaCl, 5% glycerol, 1 mM EDTA, 5 mM reduced glutathione and 1 mM oxidized glutathione) was carried out using a PD10 Sephadex G25 desalting column (GE Healthcare).
The concentration of the pooled fractions was diluted to 1 mg/ml with disulphide reshuffling buffer and incubated for 12 hours at room temperature. The reshuffled protein was injected onto a HiLoad Superdex 200 pg 16/600 column (GE Healthcare) equilibrated in resuspension buffer and resolved fractions from the size exclusion chromatography (SEC) column containing MBP-R-spondin 1 (identified by SDS-PAGE) were pooled and concentrated using an Amicon Ultra-14 centrifuge filter.
Buffer exchange was carried out using a PD10 Sephadex G25 desalting column (GE Healthcare) equilibrated in IEX buffer (50 mM Na 2+ /K + phosphate buffer pH 7.0 containing 5 % glycerol). At this stage, MBP-R-spondin 1 fusion protein can be analysed to determine concentration (using the Bradford protein assay; Bio-Rad) and used in organoid growth media at a concentration of 25 nM (see Results).
MBP-R-spondin 1 was incubated with 5 U of Thrombin (Sigma) per mg protein for 8 hours at room temperature and the cleaved R-spondin 1 moiety was resolved using cation exchange chromatography (IEX) with a HiTrap SP HP 5 ml column on an AKTA Purifier equilibrated in IEX buffer (15 mM sodium phosphate buffer containing 5% glycerol) with a linear gradient to 1 M NaCl in IEX buffer. Rspondin 1-containing fractions (identified by SDS-PAGE) were pooled, concentrated and buffer exchanged using a PD10 Sephadex column equilibrated in phosphate buffered saline buffer. The cellular activity of purified R-spondin 1 was determined by Wnt pathway reporter assay (see below).
Expression and purification of Gremlin 1
Human Gremlin 1 was expressed from a T7-based His-tag vector, His-N-Gremlin 1 (encoding amino acids 72-184 of Gremlin 1), in the E. coli strain BL21 (DE3) as follows: cells from glycerol stock were plated on L-agar plates with 100 g/ml of ampicillin and grown overnight. Cells from the plates were grown in baffled 2 L flasks in 1 L of 2xYT media until an OD600 of 0.8 at which point Gremlin1 expression was induced with 400 g/ml isopropyl -D-1-thiogalactopyranoside (IPTG) for three hours at 37°C. Cells were harvested by centrifugation for 20 minutes at 4,000 x g and stored frozen at -20C.
The frozen pellet from 1 L of Gremlin 1 expressing culture was resuspended in lysis buffer (50 mM
Tris base pH 8.0, 2 mM EDTA pH 8.0, 10 mM DTT, 0.5% Triton-X100) and lysed using an Emulsiflex . 500 g Aliquots of 500 g each were dried under vacuum in a centrifugal concentrator and stored at -80°C.
The protein is stable for at least 24 months when stored in this way.
Prior to use, purified Gremlin 1 was reconstituted in PBS buffer at a concentration of `1 mg/ml, and confirmed by Cellular activity was determined by alkaline phosphatase assay (see below).
Cellular reporter assay of R-spondin 1 activity
The cellular activity of MBP-R-spondin and R-spondin 1 fractions were determined by the ability to 
Cellular Gremlin 1 activity.
The cellular activity of purified Gremlin 1 is defined as the IC50 for inhibition of BMP2-induced cellular activity using the alkaline phosphatase assay (ALP) (7) . Optimal concentration of BMP2 for use in Gremlin 1 activity assays was determined as follows: C2C12 cells (low passage number is critical) were plated into 96-well plates and cultured in DMEM containing 10 % FBS. To determine optimal concentrations of BMP2 for the Gremlin 1 inhibition assay, a serial dilution of BMP2 (0 nM -10 nM) was added to the cells and incubated for 48 hrs. Cells were washed with PBS and alkaline phosphatase activity was measured by adding the substrate p-nitrophenyl phosphate (pNPP; Sigma Aldrich) and absorbance read at 405 nm using a PHERAstar FS plate reader. The EC50 values for BMP2 activity was calculated as 4.2 ± 0.41 nM using Graphpad Prism with a maximal activity at 10.0 nM. Activity values for each concentration of BMP2 were the average of 3 individual experimental replicates reported with SD. The sub-maximal value of 6 nM BMP2 was chosen for use in Gremlin 1 activity assays.
Determination of the Gremlin 1 IC50 for inhibition of BMP2-induced cellular activity was carried out as above, using serial dilutions of Gremlin 1 in the presence of 6 nM BMP2. IC50 were using GraphPad Prism. Activity values for each concentration of BMP2 and were the average of 4 individual experimental replicates reported with SD.
Endotoxin assay
Levels of endotoxin in the R-spondin 1 and Gremlin 1 preparations was determined using the 
Optimisation of R-spondin 1 and Gremlin 1 concentration in media formulations
Optimisation of R-spondin 1 and Gremlin 1 concentrations for use in media for culture of murine small intestinal epithelial organoids were determined by growing organoids in individual wells with variable concentrations of R-spondin 1 (0 -100 nM) or Gremlin 1 (0 -25 nM) in otherwise fully-supplemented organoid growth media. Growth characteristics (multiplicity and crypt number) of organoids were tested 8 days post-plating. Organoid multiplicity was determined by determining the average count of organoids in each condition form 8 different wells, reported with SD. Organoid crypt number was determined as the average number of crypts from 10 organoids in individual wells. Crypt numbers were subsequently averaged across 8 wells, reported with SD.
Results
The R-spondin family and the Noggin and Gremlin BMP inhibitor families are essential growth factors for culturing organoids derived from a number of epithelial tissues. We report here a key refinement in the culture of organoids -the use of highly pure preparations of R-spondin 1 and Gremlin 1 of defined cellular activities derived from bacterial expression
Production of R-spondin 1
The expression vector for R-spondin 1 ( Fig. 2A) has been modified from a previous report (12) to include the coding sequence for the 9 amino acid Avi-tag fused to the N-terminus of the R-spondin 1 that confers enhanced solubility and specific activity of the expressed protein.
R-spondin activity is particularly sensitive to the correct configuration of disulphide linkages. In addition to the R-spondin 1 expression cassette, pR-spondin 1 drives expression of DsbC, a disulphide isomerase that promotes the correct configuration of disulphide linkages. We express R-spondin 1 in the NEB Shuffle T7 E. coli expression strain that also expresses additional DsbC in the cytoplasm.
Moreover, following lysis of expressing bacteria and batch purification by Nickel-NTA agarose we subject the expressed R-spondin 1 to an in vitro disulphide shuffling step in the presence of reduced and oxidised glutathione. Nonetheless, a subsequent SEC step removes approximately 50% of the inactive, insoluble R-spondin 1 protein from preparation yielding pure MBP-R-spondin 1 that migrates as a single band of protein by SDS-PAGE at the expected molecular mass of 58 kDa (Fig. 2B ). Cellular activities of the MBP-R-spondin 1 fractions (WPC50s) increase greater than 10-fold with SEC, from 79.3 nM to 6.6 nM (Fig. 2B) . The purified MBP-R-spondin can be used to supplement organoid media for routine use at a concentration of 25 nM.
Removal of the MBP moiety by Thrombin cleavage and cation exchange chromatography produces pure R-spondin 1 with a cellular activity of 6.8 nM, similar to MBP-R-spondin 1 after SEC. R-spondin 1 migrates on SDS-PAGE gels as a single band at the expected molecular mass of 16 kDa (Fig. 2B) .
By contrast, commercially-sourced R-spondin 1 (CS-R-spondin 1) migrates as a 40 kDa protein instead of the expected 26 kDa (predicted from the sequence), presumably due to glycosylation. Note that the CS-R-spondin retains 118 amino acids at the C-terminus not present in bacterially-derived R-spondin 1.
A typical yield of purified MBP-R-spondin 1 and R-spondin 1 is approximately 2. Typical levels of contaminating endotoxin in the final MBP-R-spondin 1 and R-spondin 1 preparations are similar to CS-R-spondin 1 and > 20-fold less than the LOCE threshold value of 0.5 EU/ml endotoxin when diluted into organoid culture media ( Table 2) .
Production of Gremlin 1
The vector for bacterial expression of recombinant human Gremlin 1 (His-N-Gremlin 1) and the purification procedure has previously been described (5) . Bacterially-expressed recombinant Gremlin 1 associates with inclusion bodies requiring suspension of the protein under denaturing conditions and a refolding/disulphide shuffling step for generation of natively-folded protein. Subsequent anion exchange chromatography leads to an essentially pure preparation of Gremlin 1 that can be used in organoid media formulations at a concentration of 25 nM.
A final reverse phase chromatography step resolves a highly pure fraction of Gremlin 1 shown by a single band on SDS-PAGE migrating at the expected molecular mass of 14 kDa (Fig. 3B) . By contrast, the 30 kDa commercially-sourced Gremlin (CS-Gremlin) protein, consisting of amino acids 25-284, migrates as two bands on SDS-PAGE gels, one at approximately 27 kDa and the other at the expected 30 kDa (Fig.3B) . The reduced mobility and diffuseness of CS-Gremlin migration is typical of glycosylated proteins derived from eukaryotic expression systems.
The cellular activity of bacterially-produce Gremlin-1 is measured as the IC50 for the inhibition of BMP2-induced alkaline phosphatase expression in C2C12 cells per M protein -typical values for bacterially-expressed Gremlin 1 are ( Fig. 3B ; Table 2 ). Endotoxin levels are approximately 250-fold lower that the LOCE threshold (Table 2) 
Use of R-spondin 1 and Gremlin 1in organoid media formulation
We compared the ability of bacterially-derived R-spondin 1 and Gremlin 1 with the corresponding commercially-sourced growth factors, CS-R-spondin 1 and CS-Gremlin 1 to sustain growth of murine small intestinal epithelial organoids. We find that the activities of R-spondin 1 and CS-R-spondin 1 are similar, each sufficient at a minimum concentration of 5 nM to fully support the growth of organoid cultures (Fig. 4A) . We analysed crypt multiplicity in organoids as a more sensitive probe of R-spondin 1 activity. The addition of bacterially-derived R-spondin 1 or CS-R-spondin 1 to organoid media display similar activities after 8 days of growth with a minimum concentration of 25 nM yielding the maximal number of 15 crypts per organoid.
The addition of Gremlin to organoid media is not strictly required for growth; we find that media formulations that lack Gremlin 1 and other BMP signalling inhibitors (such as Noggin) can sustain growth of murine intestinal epithelial organoids for up to 2-3 passages as previously described (13) .
Gremlin 1 or CS-Gremlin 1 have similar activities in organoid media and at 10 nM either protein sustains long-term organoid cultures (Fig. 4C) . Analysis of crypt multiplicity after 8 days growth
indicates that a minimum of 25 nM Gremlin 1 or CS-Gremlin 1 yields the maximum number of crypts per organoid.
Application to organoids derived from a range of tissue types
We tested the ability of bacterially-derived R-spondin 1 and N-Gremlin 1 in corresponding media formulations (Table 1) to support sustained culture of organoids derived from a number of murine tissues including colon epithelia, APC min/-small intestinal tumours and mammary gland ( Figs 5A, B and C) as well as organoids derived from clinical biopsies of human colon epithelia and patient-matched colon cancer tumours ( Fig. 5D ; media formulations in Table 1 ). In all cases, media containing bacterially-expressed R-spondin 1 and N-Gremlin 1 supported robust organoid growth indicating wide application of our protocols.
Discussion
Organoid culture, though still being refined for some epithelial tissues, is fast becoming an essential laboratory tool. Current implementation of organoid technology has graduated from proof-in-principle studies to hypothesis testing in the field of epithelial autonomous physiology, research into the molecular underpinnings of genetic diseases such as cancer (2) and cystic fibrosis (14) and the recapitulation of epithelial and tumour microenvironments (15) and host-virus interactions (16) . We report here the production of highly pure Gremlin 1 and R-spondin 1, of known cellular activities, derived from bacterial expression for use in organoid media. The protocol we outline has three major advantages over conventional use of Gremlin 1 and R-spondin 1 from conditioned media or commercial sources: (i) highly pure R-spondin 1 and Gremlin 1 is devoid of impurities such as serum-derived growth factors; (ii) the use of precise cellular activities of the growth factors minimising the effects of batch-to-batch variability. ii) a substantial reduction in cost of organoid media. The protocol we outline for the generation if media containing recombinant R-spondin 1 and Gremlin 1 is therefore a leap forward in the ability to generate reproducible growth conditions for both routine organoid culture and large-scale applications such as genetic and chemical screens or clinical tissue biobanking previously reported for limited sample sets of colon cancers (2, 3) . We have further demonstrated the applicability of bacterially-derived growth factor production for the culture of organoids derived from a range of tissues including murine small intestine and colon epithelia, mammary gland and human colon epithelia and colon cancer biopsies. We envision that the use of organoid media formulations with defined cellular activities of growth factors will spur the emergence of new applications for organoids that, in particular, require large-scale, cost-effective culture.
Figures Figure 1. Overview of the procedure
The generation of recombinant R-spondin 1 and Gremlin and subsequent characterisation steps for use in organoid media are as follows:
Step I -Recombinant growth factors R-spondin 1 and Gremlin 1 are expressed in bacteria and purified.
Step II -Specific activities of Gremlin 1 and R-spondin 1 are determined from cellular reporter assays.
Step III -A quality control step is used to ensure minimum endotoxin levels (derived from growth factor expressing bacteria) are present in the preparations using the limulus amoeboid lysate (LAL) assay.
Step IV -media formulated with defined activities of Rspondin 1 and Gremlin 1 is tested for the ability to support growth of murine intestinal epithelial organoids.
We have further outlined abridged purification protocols for Gremlin 1 and R-spondin 1 in the Materials and Methods, suited to laboratories without access to production-scale chromatography equipment, that produce pure growth factors of sufficient cellular activity for routine organoid culture. The corresponding media formulations (Table 1) * Base media is DMEM/F12 media containing 2 mM glutamine, 10 mM HEPES and 0.5 U/ml Penicillin/streptomycin Step I
Step II
Step III
Step IV growth factor production QC1. Determination of specific activity QC2. Endotoxin assay
QC3. Test growth factors
C.
A. 
